A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples